Beauty Health (SKIN)
(Delayed Data from NSDQ)
$3.36 USD
+0.13 (4.02%)
Updated May 3, 2024 04:00 PM ET
After-Market: $3.36 0.00 (0.00%) 7:02 PM ET
3-Hold of 5 3
B Value B Growth C Momentum B VGM
The Beauty Health Company (SKIN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$3.92 | $5.00 | $3.00 | 21.36% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for The Beauty Health Company comes to $3.92. The forecasts range from a low of $3.00 to a high of $5.00. The average price target represents an increase of 21.36% from the last closing price of $3.23.
Analyst Price Targets (6 )
Broker Rating
The Beauty Health Company currently has an average brokerage recommendation (ABR) of 3.18 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms. The current ABR compares to an ABR of 3.18 a month ago based on 11 recommendations.
Of the 11 recommendations deriving the current ABR, two are Strong Buy, representing 18.18% of all recommendations. A month ago, Strong Buy represented 18.18%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 6 | 6 | 6 | 6 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 3 | 3 | 3 | 3 | 3 |
ABR | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/18/2024 | The Benchmark Company | Bruce D Jackson | Hold | Hold |
3/13/2024 | Piper Sandler | Korinne N Wolfmeyer | Strong Sell | Strong Sell |
3/1/2024 | D.A. Davidson | Linda B Weiser | Strong Buy | Strong Buy |
2/29/2024 | Canaccord Genuity | Susan K Anderson | Hold | Hold |
11/14/2023 | Raymond James | Olivia Tong | Hold | Strong Sell |
11/14/2023 | William Blair | Margaret Kaczor | Strong Buy | Hold |
9/19/2023 | Imperial Capital | Michael Piccolo | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.18 |
ABR (Last week) | 3.18 |
# of Recs in ABR | 11 |
Average Target Price | $3.92 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 73 of 252 |
Current Quarter EPS Est: | -0.14 |